Real-time enrollment status for this mixed dyslipidemia clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06497127 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Mixed Dyslipidemia |
| Phase | Clinical Trial |
| Target Enrollment | 132 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Shanghai Argo Biopharmaceutical Co., Ltd. |
| Last Updated on CT.gov | January 13, 2026 (Jan 13, 2026) |
As of March 2, 2026: Clinical trial NCT06497127 is currently active_not_recruiting participants. This clinical trial study for mixed dyslipidemia is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Shanghai Argo Biopharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06497127 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06497127 was last updated Jan 13, 2026 (January 13, 2026). HelloStudys verifies this status automatically.